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ABSTRACT 
 
Adrenaline has been shown to modulate proliferation of mouse fibroblasts, adventitial fi-
broblasts and synovial B (fibroblasts-like) cells. However, little is known about the response 
of cultured human hypertrophic scar fibroblasts to adrenaline. In this study, we investigated 
cell proliferation and involved mechanisms in hypertrophic scar fibroblasts in response to 
adrenaline. Population doubling time (PDT) assay and MTT assay were performed to deter-
mine the cell proliferation and cell viability, respectively. The expression of bFGF and TGF-
β1 was measured by reverse transcriptase-polymerase chain reaction (RT-PCR) and enzyme 
linked immunosorbent assay (ELISA). The results showed that adrenaline inhibited prolifera-
tion of normal and hypertrophic scar fibroblasts in a dose-dependent manner. Moreover, 
adrenaline up-regulated the expression of bFGF and down-regulated the expression of TGF-
β1 in normal and hypertrophic scar fibroblasts. Interestingly incubation with the α receptor 
antagonist regitine indicated that adrenaline mediated inhibition of cell proliferation and regu-
lation of TGF-β1 and bFGF in cultured normal and hypertrophic scar fibroblasts were medi-
ated by the α receptor. These studies suggest that adrenaline inhibits proliferation and alters 
the expression of TGF-β1 and bFGF in human hypertrophic scar fibroblast involving an α 
receptor mediated pathway. 
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INTRODUCTION 
 
Wound healing is a normal reaction to 
skin injury. It fulfills the necessary task of 
sealing the open wound, thus returning 
function to the skin. Ideally wound healing 
should be indistinguishable from normal 
uninjured skin, while this occurs in fetal 
wound healing. Adult wound healing usu-
ally results hypertrophic scar formation. 
The hypertrophic scar is one of problems of 
reparative surgery, which not only gives 
great burden to medicine but also does huge 
harms to patients.  
The mechanism of hypertrophic scar is 
not clear. Recent studies (Razzaque and 
Taguchi, 2003; Hunt et al. 2000) suggest 
that wound healing is a complex process 
involving interactions among a variety of 
different cell types. The normal wound re-
pair process consists of three phases – in-
flammation, proliferation, and remodeling – 
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that occur in a predictable series of cellular 
and biochemical events. Wound healing is 
affected by several factors, including local 
factors (growth factors, edema and ische-
mia, low oxygen tension, and infection), 
regional factors (arterial insufficiency, ve-
nous insufficiency, and neuropathy), sys-
temic factors (inadequate perfusion and 
metabolic disease), and other miscellaneous 
factors, such as nutritional state, preexisting 
illnesses, exposure to radiation therapy, and 
smoking. Large of investigations (Souchel-
nytskyi et al., 1996) suggest that growth 
factors play a role in cell division, migra-
tion, differentiation, protein expression, 
enzyme production and have a potential 
ability to heal wounds by stimulating an-
giogenesis and cellular proliferation, affect-
ing the production and the degradation of 
the extracellular matrix, and being chemo-
tactic for inflammatory cells and fibro-
blasts. There are seven major families of 
growth factors: epidermal growth factor 
(EGF), transforming growth factor-beta 
(TGF-β), insulin-like growth factor (IGF), 
platelet-derived growth factor (PDGF), fi-
broblast growth factor (FGF), interleukins 
(ILs), and colony-stimulating factor (CSF). 
The events of early wound healing reflect a 
finely balanced environment leading to un-
complicated and rapid wound healing. 
Chronic wounds, for many reasons, are out 
of balance. There are two key growth fac-
tors in the process of wound healing, that is, 
basic fibroblast growth factor (bFGF) and 
transforming growth factor β1 (Komarce-
vic, 2000; Tuan and Nichter, 1998). Basic 
FGF causes a dose-dependent inhibition of 
hydroxyproline biosynthesis, which is an 
index of collagen production. On the other 
hand, TGF-β1 stimulates collagen, elastin, 
and fibronectin synthesis while inhibiting 
extracellular matrix degradation. 
Fibroblasts have important effects on 
the hypertrophic scar formation, so many 
drugs especially a series of hormones inhib-
iting fibroblast proliferation and synthesis 
or releasing ECM have been applied in 
clinical. Recent investigations suggest that 
adrenaline or noradrenaline may inhibit the 
cultured neonatal mouse fibroblasts and 
adventitial fibroblasts proliferation (Saito et 
al., 1997; Zhang et al., 2002). Mishima et 
al. (2001) also found that epinephrine or 
norepinephrine dose- and time-dependently 
decrease the number of synovial B (fibro-
blast-like) cells. Other studies show that the 
cell morphology and proliferating activity 
of postburn scar-derived fibroblasts could 
wholy be inhibited by Tripterygium extract 
(LLZ) which is similar to adrenaline (Xie et 
al., 2002). Our previous study also shows 
that adrenaline can inhibit proliferation and 
induce cell apoptosis of hypertrophic scar 
fibroblasts (Zhang et al., 2005). Therefore, 
the present investigation was designed to 
delineate the mechanism of adrenaline in-
hibiting proliferation and inducing apop-
tosis of hypertrophic scar fibroblasts. 
 
MATERIALS AND METHODS 
 
Cell culture 
 
Primary cell lines of normal and hyper-
trophic scar dermal fibroblasts were estab-
lished from operating room specimens. The 
Human Subjects Committee at Nanhua 
University provided exemption for the labo-
ratory to use these operative specimens, 
which otherwise would have been dis-
carded. A standard explant method was 
used to establish the primary fibroblast cul-
tures from the operative specimens. This 
explant method was performed using sterile 
technique under a laminar flow hood. After 
all of the subcutaneous tissue was removed 
with a scalpel blade, the gross specimens 
were minced into small fragments in a petri 
dish. The specimens underwent antimicro-
bial treatment with phosphate-buffered sa-
line (PBS) solution with 5 % penicil-
lin/streptomycin/amphotericin (PSA). 
Minced fragments measuring approxi-
mately 1 mm3 were then placed into scored 
collagen-coated 75 cm2 tissue culture flasks 
containing 5 ml of explant tissue culture 
media (40 % fetal calf serum in Dulbecco's 
modified eagle medium with 1 % PSA and 
1 % l-glutamine). These flasks were then 
stored in a humidified incubator containing 
a 5 % CO2 atmosphere at 37 °C. The ex-
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plant-containing flasks were examined daily 
under light microscopy for outgrowth of 
fibroblasts from the tissue fragments. Until 
light microscopy demonstrated such fibro-
blast outgrowth, explant tissue culture me-
dia was changed daily. Once fibroblast out-
growth approached confluence, the tissue 
fragments were removed. The fibroblasts 
were then trypsinized with 0.05 % trypsin 
and subcultured into culture flasks contain-
ing 10 ml of primary culture media (10 % 
fetal calf serum in Dulbecco's modified 
eagle medium with 1 % PSA and 1 % l-
glutamine). All flasks were stored in a hu-
midified incubator containing a 5 % CO2 
atmosphere at 37 °C. Primary culture media 
was changed twice a week. Successive cul-
tures were passed at confluence. 
Experiments were performed using 
early passage cells - passage the 3rd–8th 
generations of normal and hypertrophic scar 
fibroblasts. At the time of experimentation, 
confluent fibroblasts were released from the 
culture flasks with 0.05 % trypsin. After 
visualization with light microscopy demon-
strated cell release from the flask wall, tryp-
sin soybean inhibitor was placed into each 
flask in a 1:1 ratio to inactivate the trypsin 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) (GIBCO) was then added to each 
resulting cell suspension. The concentration 
of each cell suspension was determined 
using phase-contrast microscopy. 
 
Cell treatment 
 
Equal numbers of normal or hypertro-
phic scar fibroblasts were plated and cul-
tured for 72 h in DMEM. Cells were 
washed twice with PBS and then incubated 
in DMEM containing buffer (control) or 
regitine (3×10-6 μM) for 1 h, then added 
variable concentrations of adrenaline (0, 
0.05, 0.10, 0.20 μM) into the media for 
24 h. The doses and times were determined 
in our previous study. 
 
Population doubling time (PDT) assay for 
cell proliferation determination 
 
Normal and hypertrophic scar fibro-
blasts grown in 60 mm Petri dish were 
treated as described previously, then 
washed with PBS and stained by Giemsa. 
The resulting of cell clones from each Petri 
dish was counted using phase-contrast mi-
croscopy. 
PDT (h) = (tx1g2) /lgn  
(t: culture time; n: clones) 
 
MTT assay for fibroblasts – cell viability 
determination 
 
Colorimetric MTT assay was per-
formed to assess cell viability. Briefly, 
normal and hypertrophic scar fibroblasts 
grown in 96-well plates treated as described 
previously. Then 20 μl of MTT (5 mg/ml, 
Sigma) in PBS solution was added into 
each well at a final concentration of 
5 mg/ml and then the plate was further in-
cubated for 4 h. All remaining supernatants 
were removed and 150 μl of DMSO was 
added into each well and mixed thoroughly 
to dissolve the formed crystal formazan. 
After 15 min of incubation to ensure all 
crystals being dissolved, the light absorp-
tion was measured at 490 nm using an en-
zyme-linked immunosorbent assay (ELISA) 
reader. Viability was expressed as a per-
centage of absorbance values in treated 
cells to that in control cells. 
 
LDL activity assays 
 
The leakage into the media of LDH, an 
indicator of cell injury, was detected with 
an assay kit (Jiancheng BioEngineering, 
Nanjing, China) according to the manufac-
turer's instructions. Briefly, normal and 
hypertrophic scar fibroblasts grown in 96-
well plates treated as described previously. 
At the end of the incubation, 30 μl of cell 
medium was taken out for the activity 
analysis of extracellular LDH, which could 
catalyze the conversion of lactate to pyru-
vate, and then reacted with 2,4-dinitro-
phenylhydrazine to give the brownish red 
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color in basic solution. After reaction, each 
sample was detected and the absorbance 
was read at wavelength 440 nm and the 
results were expressed as U/L of cell cul-
ture supernatants. 
 
RT-PCR for TGF-β1 and bFGF 
 
Briefly, after experimental treatments, 
normal and hypertrophic scar fibroblasts 
were washed twice with cold PBS. Then, 
total RNA was isolated using TRIZOL 
(GIBCO BRL). mRNA was then isolated 
using a mRNA isolation kit (TaKaRa Bio-
technology) and was reversely transcribed 
into first-strand cDNA. Gene expression 
was analyzed by PCR. Aliquots of the re-
sulting cDNA (3 μl) were then subjected to 
PCR amplification in the presence of 0.2 μl 
AmpliTaq polymerase (Promega, 5 u/μl), 
0.5 μl each primer (20 μM, primer se-
quence: human bFGF (28 cycles), S: 5’- 
GCT CTT AGC AGA CAT TGG AAG -3’; 
AS: 5’- GTG TGT GCT AAC CTT ACC T- 
3’, 275 bp (Takizawa et al., 2001); human 
GAPDH (28 cycles), S: 5’- GAG ATG 
ATG ACC CTT TTG GC -3’, AS: 5’- GTG 
AAG GTC GGA GTC AAC G -3’, 365 bp; 
human TGF-β1 (28 cycles), S: 5’- GCC 
CTG GAC ACC AAC TAT TGC T -3’, 
AS: 5’- AGG CTC CAA ATG TAG GGG 
CAG G -3’, 184 bp (Sakai et al., 2001), 0.5 
μl dNTP (10 mmol/L), 1.5 μl MgCl2 (25 
mmol/L) and 2.5 μl PCR buffer in a total 
volume of 25 μl. Amplification was done in 
DNA Thermal Cycler under the following 
conditions: denaturation at 94 °C for 30 s, 
annealing for 30 s (55 °C for bFGF and 
GAPDH, 60 °C for TGF-β1), and extension 
at 72 °C for 30 s, with final extension at 
72 °C for 5 min. Six microliters of each 
PCR product were subjected to electropho-
resis on agarose gel in Tris acetic acid-
EDTA buffer and stained with ethidium 
bromide. The gels were photographed and 
then analyzed by image analysis system 
(GSD8000, UVP, England). For each 
cDNA sample, the densitometric units of 
the amplified cDNA fragments were 
counted for semiquantitatively evaluation 
by normalization with the GAPDH band. 
ELISA for TGF-β1 and bFGF 
 
TGF-β1 and bFGF levels from cell cul-
ture supernatants were measured by ELISA 
kit (bFGF ELISA kit, RayBiotech, Inc. 
TGF-β1 ELISA kit, Bender Medsystems). 
Normal and hypertrophic scar fibroblasts 
grown in 96-well plates were treated as 
described previously. Then 100 µl of each 
cell culture supernatant were added into 
appropriate wells. The well with plate 
holder was covered and incubated for 
2.5 hours at room temperature. The solution 
was discarded and washed 4 times with 1x 
Wash Solution (200 µl each). 100 µl of 1x 
prepared biotinylated antibody were added 
into each well and incubated for 1 hour at 
room temperature. The solution was dis-
carded and washed 4 times with 1x Wash 
Solution (200 µl each). 100 µl of prepared 
Streptavidin solution were added into each 
well and incubated for 45 minutes at room 
temperature. The solution was discarded 
and washed 5 times with 1x Wash Solution 
(200 µl each). 100 µl of TMB One-Step 
Substrate Reagent were added to each well 
and incubated for 30 minutes at room tem-
perature in the dark. 50 µl of Stop Solution 
were added into each well and read at 
450 nm immediately. Results are expressed 
as TGF-β1 or bFGF level in pg per ml of 
cell culture supernatants. 
 
Statistical analysis 
 
A paired student’s t-test and one-way 
ANOVA was used for comparison of mean 
values. Results are from three independent 
experiments, each are expressed as mean ± 
SEM. Statistical significance was defined as 
P < 0.05. 
 
RESULTS 
 
Cell proliferation of human normal and 
hypertrophic scar fibroblasts treated by 
adrenaline  
 
The human normal and hypertrophic 
scar fibroblasts cell lines used in this study 
each exhibited exponential growth. Cellular 
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viability ranged from 92.8 % to 100 %, with 
the mean viability of each cell type control 
and treatment group ranging from 92.8 % to 
97.2 %. All control and treatment groups 
showed an initial decline in cell population 
after modulation, followed by a recovery of 
exponential proliferation. Population dou-
bling time (PDT) was calculated for control 
group and treatment group in order to com-
pare the rates of cell proliferation. PDTs 
were derived from exponential best-fit 
curves generated from the portion of each 
growth curve demonstrating exponential 
growth. The normal and hypertrophic scar 
fibroblasts control group had a PDT of 
105.0 and 98.6 hours, respectively. 
In hypertrophic scar fibroblasts, the ad-
dition of 0.05, 0.10 and 0.20 µM adrenaline 
to the experimental conditions resulted in 
significant longer PDT, increasing PDT by 
11.2 %, 19.7 % and 20.9 %, respectively 
(P < 0.01). In normal fibroblasts, the addi-
tion of 0.05, 0.10 or 0.20 µM adrenaline to 
the experimental conditions also resulted in 
significant longer PDT, increasing PDT to 
117.5, 126.0 and 129.0 hours, respectively. 
Of note, however, is that normal dermal 
fibroblasts or hypertrophic scar dermal fi-
broblast treated with 0.05, 0.10 or 0.20 µM 
adrenaline and regitine had no statistically 
significant lower cell clones at 24 hours 
than untreated fibroblasts (P > 0.05) (Table 
1). 
 
Table 1: Effect of adrenaline and regitine 
on Population doubling times of fibroblasts 
 
Fibro-  
blasts 
type 
Adrenaline 
concentr. 
(μmol/L) 
Regitine 
concentr. 
(μmol/L) 
Population  
doubling 
time (hours) 
NFB 0 0  105.0 ±  2.4 
NFB 0 3×10-6  104.5 ±  1.8 
NFB 0.05 0  117.5 ±  3.3*
NFB 0.10 0  126.0 ± 2.2*
NFB 0.20 0  129.0 ±  3.0*
NFB 0.05 3×10-6  99.5 ±  1.2 
NFB 0.10 3×10-6  100.8 ±  0.7 
NFB 0.20 3×10-6  109.7 ±  1.3 
 
Fibro- 
blasts 
type 
Adrenaline
concentr. 
(μmol/L) 
Regitine 
concentr. 
(μmol/L) 
Population 
doubling 
time (hours) 
SFB 0 0  98.6 ±  3.2 
SFB 0 3×10-6  103.0 ±  2.3 
SFB 0.05 0  110.5 ±  3.1* 
SFB 0.10 0  118.3 ±  2.7* 
SFB 0.20 0  119.2 ±  2.5* 
SFB 0.05 3×10-6  98.9 ±  3.8 
SFB 0.10 3×10-6  101.6 ±  1.5 
SFB 0.20 3×10-6  107.2 ±  1.3 
Population doubling times in cultured cells chal-
lenged by adrenaline and (or) regitine. Cultured 
cells were challenged by adrenaline (0.05-0.20 
μmol/L) and (or) regitine (3x10-6 μmol/L). The 
Population doubling times are the mean ± SEM 
of 3 independent experiments. 
* P < 0.01 vs the control group. NFB, normal 
human fibroblasts; SFB, human hypertrophic 
scar fibroblasts 
 
MTT assay showed that when hyper-
trophic scar fibroblasts treated with 0.05, 
0.10 or 0.20 μM adrenaline, the cell viabil-
ity was significantly decreased to 60.0 %, 
42.0 % and 13.0 %, respectively (P < 0.01). 
In normal fibroblasts, the addition of 
adrenaline resulted in significant decrease 
of cell viability. On the other hand, if 
regitine and 0.05, 0.10 μM adrenaline 
stimulated normal or hypertrophic scar fi-
broblasts simultaneously, the cell viability 
did not significantly decrease compared 
with the control group. However, if normal 
or hypertrophic scar fibroblasts were incu-
bated with regitine and 0.20 μM adrenaline 
at the same time, the cell viability also de-
creased, which were 78.5 % and 83.5 % 
respectively (P < 0.05). But it was still 
higher than the group of 0.20 μM adrena-
line treated fibroblasts (Table 2).  
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Table 2: Effect of adrenaline and regitine  
on the cell viability of fibroblasts 
The cell viability in cultured cells challenged by 
adrenaline and (or) regitine. Cultured cells were 
challenged by adrenaline (0.05-0.20 μmol/L) 
and (or) regitine (3x10-6 μmol/L). The cell viabil-
ity is the mean of 3 independent experiments.  
* P < 0.01 vs the control group.  
**P < 0.05 vs the control group. NFB, normal 
human fibroblasts; SFB, human hypertrophic 
scar fibroblasts. 
 
To investigate the cell toxicity of 
adrenaline or/and regitine, we determined 
LDH leakage of cell culture supernatants. 
The results suggested that adrenaline or/and 
regitine had no cell toxicity to fibroblasts 
(Table 3).  
Table 3: Effect of adrenaline and regitine on 
LDH leakage in cell culture supernatants 
Fibro- 
blasts 
Type 
Adrenaline 
concentr. 
(μmol/L) 
Regitine 
concentr. 
(μmol/L) 
LDH leakage
NFB 0 0  28.1 ± 0.23
NFB 0.20 0  27.0 ± 0.54
NFB 0.05 3×10-6  26.8 ±  0.65
NFB 0.10 3×10-6  28.2 ± 0.12
NFB 0.20 3×10-6  29.1 ±  0.09
SFB 0 0 24.8 ±  0.33
SFB 0.20 0  26.3 ±  0.42
SFB 0.05 3×10-6  23.5 ±  0.43
SFB 0.10 3×10-6  23.9 ±  0.48
SFB 0.20 3×10-6  22.8 ±  0.53
The LDH leakage in cell culture supernatants 
challenged by adrenaline and (or) regitine. Cul-
tured cells were challenged by adrenaline (0.05-
0.20 μmol/L) and (or) regitine (3x10-6 μmol/L). 
The LDH leakage is the mean ± SEM of 3 inde-
pendent experiments. NFB, normal human fi-
broblasts; SFB, human hypertrophic scar fibro-
blasts. 
 
Effect of adrenaline on TGF-β1 and bFGF 
expression 
 
Altered expression of cell TGF-β1 and 
bFGF expression has been demonstrated to 
play an important role in the induction of 
apoptosis. Therefore, we evaluated the ef-
fects of adrenaline and its receptor antago-
nist on the expression of these growth fac-
tors in normal and hypertrophic scar fibro-
blasts by RT-PCR and ELISA. As illus-
trated, adrenaline significantly enhanced 
bFGF mRNA expression in normal and 
hypertrophic scar fibroblasts and its protein 
production in cultured supernatants (Fig-
ure 1, Table 4. ). On the contrary, TGF-β1 
expression was down-regulated in response 
to adrenaline (Figure 2, Table 5). However, 
in the presence of regitine, the increment of 
bFGF expression was inhibited (Figure 1, 
Table 4), and the adrenaline-induced down-
regulation of TGF-β1 was inhibited by 
regitine either (Figure 2, Table 5). 
 
Fibro-  
blasts 
Type 
Adrenaline 
concentr. 
(μmol/L) 
Regitine 
concentr. 
(μmol/L) 
 
OD490 
 
Cell  
viability 
NFB 0 0 0.306 ± 0.012 1.00 
NFB 0.05 0 0.184 ± 0.004 0.60* 
NFB 0.10 0 0.129 ±  0.000 0.42* 
NFB 0.20 0 0.039 ± 0.011 0.13* 
NFB 0 3×10-6 0.299 ±  0.001 0.98 
NFB 0.05 3×10-6 0.359 ±  0.000 1.00 
NFB 0.10 3×10-6 0.197 ±  0.018 0.97 
NFB 0.20 3×10-6 0.240 ±  0.000 0.785** 
SFB 0.05 0 0.181 ±  0.003 0.577* 
SFB 0.10 0 0.114 ±  0.017 0.363* 
SFB 0.20 0 0.042 ±  0.000 0.133* 
SFB 0 3×10-6 0.314 ±  0.016 1.00 
SFB 0.05 3×10-6 0.295 ±  0.020 0.94 
SFB 0.10 3×10-6  0.27  ±  0.015 0.87 
SFB 0.20 3×10-6 0.262 ±  0.000 0.835** 
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Figure 1: Kinetics of bFGF mRNA accumula-
tion in cultured cells challenged by adrenaline 
and (or) regitine. Cultured cells were challenged 
by adrenaline (0.05-0.20 μmol/L) and (or) 
regitine (3x10-6 μmol/L), and samples were 
obtained for 24 hours. The expression of bFGF 
mRNA was determined by RT-PCR. GAPDH 
was used as an internal control. Blot shown is 
the representative of 3 experiments with similar 
results. Shown in the top panel is the represen-
tative of RT-PCR, and shown in the bottom 
panel are the mean ± SEM of 3 independent 
experiments.  
* P < 0.05 vs the control group (adr, 0 μmol/L 
and Reg(-)). # P < 0.05 vs the Reg(+)group in 
the same adrenaline concentration group. 
(A) Changes of bFGF mRNA expression in 
normal human fibroblasts after adrenaline and 
(or) regitine.  
(B) Changes of bFGF mRNA expression in 
human hypertrophic scar fibroblasts after 
adrenaline and (or) regitine. NFB, normal hu-
man fibroblasts; SFB, human hypertrophic scar 
fibroblasts. 
 
Table 4: Effect of adrenaline and regitine 
on the expression of bFGF in the cell cul-
ture supernatants 
 
Fibro- 
blasts 
Type 
Adrenaline
concentr. 
(μmol/L) 
Regitine 
concentr. 
(μmol/L) 
bFGF 
(pg/ml) 
NFB 0 0  5.8 ± 0.14 
NFB 0 3×10-6  5.6 ± 0.23 
NFB 0.05 0  10.9 ±  0.21*
NFB 0.10 0  11.1 ± 0.00*
NFB 0.20 0  18.6 ±  0.51*
NFB 0.05 3×10-6  6.1 ±  0.17 
NFB 0.10 3×10-6  6.5 ± 0.41 
NFB 0.20 3×10-6  9.8 ±  0.21*
SFB 0 0  4.2 ±  0.38 
SFB 0 3×10-6  4.0 ±  0.31 
SFB 0.05 0  15.3 ±  0.72*
SFB 0.10 0  19.1 ±  0.47*
SFB 0.20 0  28.1 ±  0.81*
SFB 0.05 3×10-6  5.5 ±  0.16 
SFB 0.10 3×10-6  7.1 ±  0.25 
SFB 0.20 3×10-6  13.4 ±  0.53*
 
Kinetics of bFGF protein in cultured cells su-
pernatants challenged by adrenaline and (or) 
regitine. Cultured cells were challenged by 
adrenaline (0.05-0.20 μmol/L) and (or) regitine 
(3x10-6 μmol/L), and samples were obtained for 
24 hours. The expression of bFGF protein was 
determined by ELISA. The results shown are 
the mean ± SEM of 3 independent experiments. 
* P < 0.01 vs the control group.  
 
 
A 
B 
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Figure 2: Kinetics of TGF-β1 mRNA accumula-
tion in cultured cells challenged by adrenaline 
and (or) regitine. Cultured cells were challenged 
by adrenaline (0.05-0.20 μmol/L) and (or) 
regitine (3x10-6 μmol/L), and samples were 
obtained for 24 hours. The expression of TGF-
β1 mRNA was determined by RT-PCR. GAPDH 
was used as an internal control. Blot shown is 
the representative of 3 experiments with similar 
results. Shown in the top panel is the represen-
tative of RT-PCR, and shown in the bottom 
panel are the mean ± SEM of 3 independent 
experiments.  
* P < 0.05 vs the control group (adr, 0 μmol/L 
and Reg(-)). # P < 0.05 vs the Reg(+) group in 
the same adrenaline concentration group.  
(A) Changes of TGF-β1 mRNA expression in 
normal human fibroblasts after adrenaline and 
(or) regitine.  
(B) Changes of TGF-β1 mRNA expression in 
human hypertrophic scar fibroblasts after 
adrenaline and (or) regitine. NFB, normal hu-
man fibroblasts; SFB, human hypertrophic scar 
fibroblasts. 
 
Table 5: Effect of adrenaline and regitine 
on the expression of TGF-β1 in the cell 
culture supernatants 
 
Fibro- 
blasts 
Type 
Adrenaline
concentr. 
(μmol/L) 
Regitine 
concentr. 
(μmol/L) 
TGF-β1 
(pg/ml) 
NFB 0 0 289.6 ± 8.77 
NFB 0 3×10-6 279.1 ± 5.91 
NFB 0.05 0 199.7 ±  7.67*
NFB 0.10 0 146.7 ± 1.56*
NFB 0.20 0 130.1 ±  3.27*
NFB 0.05 3×10-6 294.5 ±  5.91 
NFB 0.10 3×10-6 289.5 ± 5.27 
NFB 0.20 3×10-6 238.6 ±  2.28*
SFB 0 0 427.1 ±  5.63 
SFB 0 3×10-6 431.6 ±  4.73 
SFB 0.05 0 381.1 ±  3.00*
SFB 0.10 0 337.4 ±  1.59*
SFB 0.20 0 364.0 ±  1.08*
SFB 0.05 3×10-6 430.1 ±  2.96 
SFB 0.10 3×10-6 418.7 ±  5.62 
SFB 0.20 3×10-6 398.2 ±  2.34*
Kinetics of TGF-β1 protein in cultured cells su-
pernatants challenged by adrenaline and (or) 
regitine. Cultured cells were challenged by 
adrenaline (0.05-0.20 μmol/L) and (or) regitine 
(3x10-6 μmol/L), and samples were obtained for 
24 hours. The expression of TGF-β1 protein 
was determined by ELISA. The results shown 
are the mean ± SEM of 3 independent experi-
ments.  
* P < 0.01 vs the control group. 
 
DISCUSSION 
 
Damage inflicted by surgical or trau-
matic injury triggers wound healing, a nec-
essary process that aims to quickly replace 
the injury with functional tissue. Intricate 
interactions between growth factors, prote-
ases, and cells result in cellular proliferation 
with synthesis of the extracellular matrix. 
The hypertrophic scar is skin abnormalities 
that is unique to humans and is character-
ized by excessive deposition of collagen in 
the dermis and subcutaneous tissues secon-
dary to traumatic or surgical injuries. A lot 
A 
B 
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of studies (Gauldie et al., 1999; Razzaque et 
al., 1999; Mutsaers et al., 1997; Razzaque 
and Taguchi, 2002) have shown that the 
proliferation of matrix-producing cells (fi-
broblasts) with subsequent overproduction 
and accumulation of matrix proteins con-
tributes to various human and experimental 
fibrotic diseases. In the hypertrophic scar 
formation, there is the proliferation of der-
mal fibroblasts and overproduction of 
ECM, too. The hypertrophic scar presents 
major challenges in clinical practice be-
cause effective antifibrotic agents are not 
yet widely available. 
The results from our study support that 
adrenaline alters cellular proliferation for 
human normal and hypertrophic scar der-
mal fibroblast populations in a dose-
dependent manner. The normal and hyper-
trophic scar fibroblasts in our study re-
sponded to adrenaline, by slowing popula-
tion doubling in a dose-dependent manner. 
Moreover, in normal and hypertrophic scar 
fibroblasts, the addition of 0.05, 0.10 and 
0.20 μM adrenaline into the experimental 
conditions resulted in somewhat decrease of 
the cell viability, decreasing to 60 %, 
42.0 %, 13.0 % and 57.7 %, 36.3 %, 
13.3 %, respectively. Saito et al. (1997) also 
found that adrenaline, noradrenaline and 
cortisol among the circulation in postopera-
tive patients inhibited the growth of cul-
tured neonatal mouse fibroblasts. Our pre-
vious studies suggested that adrenaline also 
induced apotposis (Zhang et al., 2005). 
To investigate the mechanism of 
adrenaline inducing apoptosis of fibro-
blasts, we used α receptor inhibitor - 
regitine addying into the experimental con-
ditions. Modulation of normal or hypertro-
phic scar fibroblasts with regitine and 
adrenaline did not result in a statistically 
alteration in cell viability compared with 
controls. The results suggest that these re-
sponses to adrenaline in fibroblasts were 
inhibited by the alpha receptor inhibitor. 
Zhang et al. (2002) demonstrated that high 
norepinephrine concentrations (10 mM) 
inhibited adventitial fibroblasts prolifera-
tion and this inhibition was mediated by 
alpha (2)-ARs. Mishima et al. (2001) also 
found that epinephrine or norepinephrine 
dose- and time-dependently decreased the 
number of synovial B (fibroblast-like) cells. 
Cytokines and growth factors secreted 
by inflammatory cells and by fibroblasts 
play an important role in the hypertrophic 
scar formation by regulating the prolifera-
tion of fibroblasts and the accumulation of 
ECM. Growth factors, such as bFGF and 
TGF-β1, may play a key role in the wound-
ing healing. Recent studies (Takehara, 
2000; Isaka et al., 2000; Liu et al., 2002; 
Polo et al., 1999) suggest that TGF-β1 is 
consistently found to be up-regulated in 
various human and experimental fibrotic 
diseases, and blocking its bioactivity can 
suppress the matrix production and modu-
late the fibrotic process. In addition, it dose 
not only increase the transcription of colla-
gens, but also decreases its degradation by 
inhibiting collagenase activity through in-
crease production of matrix metallopro-
teinase inhibitors such as TIMP and plas-
minogen activator inhibitor. Kamamoto et 
al. (2003) used an experimental model 
where collagen gels populated by human 
fibroblasts underwent progressive contrac-
tion, allowing the study of wound healing 
remodeling and found TGF-β resulting in 
an increase in gel contraction. A study (Luo 
et al., 2002) of SD rats found that in the 
groups receiving antisense ODN and re-
combinant plasmid, the expression of TGF-
β1 mRNA and protein was reduced during 
14 days after burn. In the control group, 
type I collagen mRNA occurred at the sec-
ond week and reached a peak value at the 
fourth week, while the antisense groups 
kept low expression of type I collagen and 
showed mild inflammatory reaction and 
less synthesis of collagen. Then, they con-
cluded that antisense TGF-β1 could prevent 
the scar formation during wound healing. 
Saed and Diamond (2003) also had similar 
results in human peritoneal fibroblasts. 
Now we have known that fetal skin wounds 
heal rapidly without the scarring and in-
flammation accompanying adult skin 
wounds. The mechanism of the scarless 
fetal repair is unclear. Series of studies led 
to the hypothesis that scarless fetal wounds 
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may be relatively TGF-β1 deficient. A de-
velopment in vivo study of SD rats found 
that the level of TGF-β1 could not be de-
tected in the early embryogeny, which is 
scarless wound healing, while was elevated 
after born (Hsu et al., 2001). The similar 
results also have been found in sheep and 
human (Beredjiklian et al., 2003; Chen et 
al., 2002). These findings suggest that anti-
TGF-β1 therapeutic strategies may amelio-
rate scar formation in adult.  
Basic fibroblast growth factor, a single-
chain polypeptide of 146 amino acids, 
causes a dose-dependent inhibition of hy-
droxyproline biosynthesis, an index of col-
lagen production and opposes the fibrotic 
signal of TGF-β1 by inhibiting collagen 
synthesis and stimulating collagen degrada-
tion (Tan et al., 1993). Carroll and Koch 
(2003) demonstrated that heparin decreased 
dermal fibroblast proliferation and collagen 
production by increasing the levels of basic 
fibroblast growth factor (bFGF). A recent 
study (Wan et al., 2002) suggested that 
bFGF could reduce the promoter activities 
of human alpha 1(I) procollagen gene and 
antagonize the role of TGF-β1 in up-
regulating the promoter activities of human 
alpha 1(I) procollagen gene in normal skin 
and hyertrophic scar fibroblasts. Other stud-
ies (Funato et al., 1997; Akasaka et al., 
2004; Spyrou and Naylor, 2002) showed 
that bFGF also promoted the apoptosis of 
hypertrophic scar fibroblast and inhibited 
fibroblast converting to myofibroblast.  
The results of the present study demon-
strate that adrenaline inhibits TGF-β1 pro-
tein synthesis but stimulates bFGF protein 
synthesis in human normal and hypertro-
phic scar fibroblasts. Moreover, alpha-
receptor antagonist significantly alters the 
effects of adrenaline on these two growth 
factors. These results suggest that the 
adrenaline may inhibit fibroblast prolifera-
tion and induce fibroblast apoptosis by de-
creasing the expression of TGF-β and in-
creasing the expression of bFGF. 
In summary, adrenaline inhibits normal 
and hypertrophic scar fibroblasts prolifera-
tion by the binding to alpha-receptor. 
Adrenaline increases bFGF production and 
decreases TGF-β1 production by normal 
and hypertrophic scar fibroblasts probably 
through the pathway of alpha-receptor. Our 
study indicates that adrenaline may mediate 
its clinical effects on hypertrophic scar by 
altering cell proliferation and the produc-
tion of bFGF and TGF-β1.  
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